NFE2L2 and diabetic neuropathy: In light of our current behavioral results obtained in a mouse model, we can only hypothesize that inhibition of MAPK signaling, activation of Nrf2 and/or blockade of NMDA receptors play a role in astaxanthin-induced analgesia in diabetic neuropathy.